1228973

Celgene Corporation — FEI 3004991673

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 31, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Summit, NJ (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)